These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25100108)

  • 1. The role of intravenous vasodilators in acute heart failure management.
    Piper S; McDonagh T
    Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilators in the treatment of acute heart failure: what we know, what we don't.
    Metra M; Teerlink JR; Voors AA; Felker GM; Milo-Cotter O; Weatherley B; Dittrich H; Cotter G
    Heart Fail Rev; 2009 Dec; 14(4):299-307. PubMed ID: 19096932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vasodilators in heart failure.
    Zamani P; Greenberg BH
    Curr Heart Fail Rep; 2013 Mar; 10(1):1-11. PubMed ID: 23299783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasoactive and inotropic drugs in acute heart failure].
    Ruiz-Laiglesia FJ; Camafort-Babkowski M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():49-54. PubMed ID: 24930084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
    Heywood JT; Khan TA
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
    Givertz MM; Teerlink JR; Albert NM; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Fang JC; Hernandez AF; Katz SD; Krishnamani R; Stough WG; Walsh MN; Butler J; Carson PE; Dimarco JP; Hershberger RE; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Starling RC
    J Card Fail; 2013 Jun; 19(6):371-89. PubMed ID: 23743486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do engineered natriuretic peptides have greater therapeutic potential than do native peptides?
    From AH
    Cardiovasc Res; 2010 Dec; 88(3):391-2. PubMed ID: 20935165
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and novel pharmacological approaches to renal insufficiency in heart failure.
    Hindnavis V; Tang WH
    Minerva Cardioangiol; 2006 Dec; 54(6):753-62. PubMed ID: 17167387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic therapy for acute heart failure.
    Tang WH
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of BNP in heart failure. Shortages of a current review reflect th complexity of the problem].
    Lindstedt G; Alehagen U; Dahlström U
    Lakartidningen; 2004 Feb; 101(8):688-9. PubMed ID: 15024944
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database.
    Nagai T; Iwakami N; Nakai M; Nishimura K; Sumita Y; Mizuno A; Tsutsui H; Ogawa H; Anzai T;
    Int J Cardiol; 2019 Apr; 280():104-109. PubMed ID: 30674432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical review and recommendations for nesiritide use in the emergency department.
    Collins SP; Hinckley WR; Storrow AB
    J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacologic therapies in development for acute decompensated heart failure.
    Ezekowitz JA
    Curr Cardiol Rep; 2013 Feb; 15(2):329. PubMed ID: 23314727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natriuretic peptides in the therapy of acute decompensated heart failure].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1738-43. PubMed ID: 21877307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides in therapy for decompensated heart failure.
    Gassanov N; Biesenbach E; Caglayan E; Nia A; Fuhr U; Er F
    Eur J Clin Pharmacol; 2012 Mar; 68(3):223-30. PubMed ID: 21901345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.